Amryt Pharma plc American Depositary Shares
AMYT
AMYT was delisted on the 11th of April, 2023.
67 hedge funds and large institutions have $348M invested in Amryt Pharma plc American Depositary Shares in 2022 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 16 increasing their positions, 13 reducing their positions, and 8 closing their positions.
339% more call options, than puts
Call options by funds: $145K | Put options by funds: $33K
63% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 8
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
23% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 13
8% more funds holding
Funds holding: 62 → 67 (+5)
11% less capital invested
Capital invested by funds: $390M → $348M (-$42.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCM
Highbridge Capital Management
New York
|
+$37.9M |
| 2 |
Handelsbanken Fonder
Stockholm,
Sweden
|
+$11.9M |
| 3 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$9.67M |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$3.14M |
| 5 |
SB
Samsara BioCapital
Palo Alto,
California
|
+$2.52M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$21.5M |
| 2 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$1.78M |
| 3 |
AG
Artal Group
Luxembourg
|
-$1.63M |
| 4 |
NFGH
Nan Fung Group Holdings
Kai Tak,
Hong Kong
|
-$207K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$167K |
AMYT Hedge Fund Activity: Q1 2022 in Review
67 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Amryt Pharma plc American Depositary Shares (AMYT) for Q1 2022, worth a combined $348M — down 11% from $390M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new AMYT positions and 8 closed out — a net gain of 5 holders — while 16 added to existing stakes and 13 trimmed.
The largest buyer was Highbridge Capital Management, adding an estimated $37.9M. The largest seller was UBS O'Connor, exiting entirely with an estimated $21.5M sold.
- 67 institutional investors held Amryt Pharma plc American Depositary Shares (AMYT) as of Q1 2022, up from 62 in Q4 2021.
- Funds reported $348M of Amryt Pharma plc American Depositary Shares stock for Q1 2022, down 11% quarter-over-quarter.
- 13 funds opened new Amryt Pharma plc American Depositary Shares positions in Q1 2022 and 8 closed out, a net change of +5 holders.
- The largest Amryt Pharma plc American Depositary Shares buyer in Q1 2022 was Highbridge Capital Management, an estimated $37.9M added.
- The largest Amryt Pharma plc American Depositary Shares seller in Q1 2022 was UBS O'Connor, an estimated $21.5M sold.
Based on aggregated 13F filings for Q1 2022.